Markers of endothelial damage in patients on hemodialysis and hemodiafiltration

Journal of Nephrology

Volumn 19, Issue 2, 2006, Pages 150-154

  Małyszko, Jacek S ^a   Małyszko, Jolanta ^a   Hryszko, Tomasz ^a   Koźminski, Piotr ^b   Pawlak, Krystyna ^a   Mysliwiec, Michal ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Regional Hospital   (Poland)

Author keywords

Endothelium; Hemodialfiltration; Hemodialysis; Hemostasis; Thrombomodulin; von Willebrand factor

Indexed keywords

BIOLOGICAL MARKER; ENOXAPARIN; HEPARIN; LIPID; THROMBOMODULIN; VON WILLEBRAND FACTOR;

ARTICLE; BLOOD CELL COUNT; BLOOD CLOTTING DISORDER; CLINICAL ARTICLE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENDOTHELIUM LESION; FEMALE; HEMODIAFILTRATION; HEMODIALYSIS; HEMOSTASIS; HUMAN; INTERMETHOD COMPARISON; KIDNEY FAILURE; LIPID BLOOD LEVEL; MALE; RENAL REPLACEMENT THERAPY;

ADULT; BIOLOGICAL MARKERS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; HEMODIAFILTRATION; HEMOSTASIS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE;

EID: 33748870198     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Kroll MH, Hellums JD, McIntire LV, Schafer AI, Moake JL. Platelets and shear stress. Blood 1996; 88: 1525-41.
2. Llach F. Hypercoagulability renal vein thrombosis and other thrombotic complications of nephrotic syndrome. Kidney Int 1985; 28: 429-39.
3. Malyszko J, Malyszko JS, Mysliwiec M. Comparison of hemostasis between CAPD and HD patients. Perit Dial Int 2001; 21: 158-65.
4. Klingel R, Schaefer M, Schwarting A, Himmelsbach F, Altes U, Uhlenbusch-Korwer I, Hafner G. Comparative analysis of procoagulatory activity of haemodialysis, haemofiltration and haemodiafiltration with a polysulfone membrane (APS) and with different modes of enoxaparin anticoagulation. Nephrol Dial Transplant 2004; 19: 164-70.
5. Bolton CH, Downs LG, Victory JG, Dwight JF, Tomson CR, Mackness MI, Pinkney JH. Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and proinflammatory cytokines. Nephrol Dial Transplant 2001; 16: 1189-97.
6. Bombeli T, Mueller M, Haeberli A. Anticoagulant properties of the vascular endothelium. Thromb Haemost 1997; 77: 408-23.
7. Tomura S, Nakamura Y, Deguchi F, Chida Y, Ohno Y, Kodama S, Hayashi T, Suzuki K, Marumo F. Plasma von Willebrand factor and thrombomodulin as markers of vascular disorders in patients undergoing regular hemodialysis therapy. Thromb Res 1990; 58: 413-9.
8. Koc M, Richards HB, Bihorac A, Ross EA, Schold JD, Segal MS. Circulating endothelial cells are associated with future vascular events in hemodialysis patients. Kidney Int 2005; 67: 1078-83.
9. Malyszko J, Malyszko JS, Brzosko S, Wolczynski S, Mysliwiec M. Adiponectin is related to CD146, a novel marker of endothelial cell activation/injury in chronic renal failure and peritoneally dialyzed patients. J Clin Endocrinol Metab 2004; 89: 4620-7.
10. McCarthy JT, Moran J, Posen G, Leypoldt JK, Hull AR, Jaber BL, Correa-Rotter R. A time for rediscovery: chronic hemofiltration for end-stage renal disease. Semin Dial 2003; 16: 199-207.
11. Vaslaki L, Karatson A, Voros P, Major L, Petho F, Ladanyi E, Weher C, Mitteregger R, Falkenhagen D. Can sterile and pyrogen-free on-line substitution fluid be routinely delivered? A multicentric study on the microbiological safety of on-line haemodiafiltration. Nephrol Dial Transplant 2000; 15 (suppl 1): S74-8.
12. Beerenhout CH, Kooman JP, Luik AJ, Jeuken-Mertens SG, Van Der Sande FM, Leunissen KM. Optimizing renal replacement therapy - a case for online filtration therapies? Nephrol Dial Transplant 2002; 17: 2065-70.
13. Altieri P, Sorba G, Bolasco P, Ledebo I, Ganadu M, Ferrara R, Menneas A, Asproni E, Casu D, Passaghe M, Sau G, Cadinu F; Sardinian Study Group on Hemofiltration On-line. Comparison between hemofiltration and hemodiafiltration in a long-term prospective cross-over study. J Nephrol 2004; 17: 414-22.
14. Wizemann V, Kulz M, Techert F, Nederlof B. Efficacy of haemodiafiltration. Nephrol Dial Transplant 2001; 16 (suppl 4): S27-30.
15. Maduell F, del Pozo C, Garcia H, Sanchez L, Hdez-Jaras J, Albero MD, Calvo C, Torregrosa I, Navarro V. Change from conventional haemodiafiltration to on-line haemodiafiltration. Nephrol Dial Transplant 1999; 14: 1202-7.
16. Altieri P, Sorba GB, Bolasco PG, Bostrom M, Asproni E, Ferrara R, Bolasco F, Cossu M, Cadinu F, Cabiddu GF, Casu D, Ganadu M, Passaghe M, Pinna M. On-line predilution hemofiltration versus ultrapure high-flux hemodialysis: a multicenter prospective study in 23 patients. Sardinian Collaborative Study Group of On-Line Hemofiltration. Blood Purif 1997; 15: 169-81.
17. Ledebo I. Does convective dialysis therapy applied daily approach renal blood purification? Kidney Int Suppl 2001; 78: S286-91.
18. Opatrny K Jr, Polanska K, Krouzecky A, Vit L, Novak I, Kasal E. The effect of heparin rinse on the biocompatibility of continuous veno-venous hemodiafiltration. Int J Artif Organs 2002; 25: 520-8.
19. Garcia-Fernandez N, Lavilla FJ, Rocha E, Purroy A. Haemostatic changes in systemic inflammatory response syndrome during continuous renal replacement therapy. J Nephrol 2000; 13: 282-9.
20. Garcia-Fernandez N, Montes R, Purroy A, Rocha E. Hemostatic disturbances in patients with systemic inflammatory response syndrome (SIRS) and associated acute renal failure (ARF). Thromb Res 2000; 100: 19-25.
21. Vaslaki LR, Berta K, Major L, Weber V, Weber C, Wojke R, Passlick-Deetjen J, Falkenhagen D. On-line hemodiafiltration does not induce inflammatory response in end-stage renal disease patients: results from a multicenter cross-over study. Artif Organs 2005; 29: 406-12.
22. Vaslaki L, Weber C, Mitteregger R, Falkenhagen D. Cytokine induction in patients undergoing regular online hemodiafiltration treatment. Artif Organs 2000; 24: 514-8.
23. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, Malatino LS, Bonanno G, Seminara G, Rapisarda F, Fatuzzo P, Buemi M, Nicocia G, Tanaka S, Ouchi N, Kihara S, Funahashi T, Matsuzawa Y. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 2002; 13: 134-41.
24. Penne LE, Blankestijn PJ, Bots ML, van den Dorpel MA, Grooteman MP, Nube MJ, ter Wee PM on behalf of the CONTRAST Group. Resolving controversies regarding hemodiafiltration versus hemodialysis: the Dutch Convective Transport Study. Semin Dial 2005; 18: 47-51.